Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
Active, not recruiting · NCT05809830 · Registry updated 2025-03-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas | Advanced Soft-tissue Sarcoma | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-21 | NCT05809830 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grupo Espanol de Investigacion en Sarcomas | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínico San Carlos | Madrid | Spain | 29 |
| Hospital Clínico Universitario de Valencia | Valencia | Spain | 17 |
| Hospital Clínico Universitario Virgen de la Arrixaca | Murcia | Spain | 9 |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | 2 |
| Hospital Fundación Jiménez Díaz | Madrid | Spain | 1 |
| Hospital Universitario La Paz | Madrid | Spain | 46 |